Učitavanje...
Budesonide–formoterol (inhalation powder) in the treatment of COPD
The budesonide–formoterol dry powder inhaler (Symbicort(®) Turbuhaler(®) 160/4.5–640/18 μg/day) contains the long-acting β(2)-adrenoreceptor agonist formoterol and the inhaled corticosteroid budesonide. Two large, 12-month trials examined the effect of budesonide–formoterol 160/4.5 μg twice daily in...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2006
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2706613/ https://ncbi.nlm.nih.gov/pubmed/18046888 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|